Literature DB >> 33574821

The Choroid Plexus Is Permissive for a Preactivated Antigen-Experienced Memory B-Cell Subset in Multiple Sclerosis.

Jürgen Haas1, Henriette Rudolph2, Leonardo Costa1, Simon Faller1, Saskia Libicher1, Cornelia Würthwein1, Sven Jarius1, Hiroshi Ishikawa3, Carolin Stump-Guthier2, Tobias Tenenbaum2, Christian Schwerk2, Horst Schroten2, Brigitte Wildemann1.   

Abstract

The role of B cells in multiple sclerosis (MS) is increasingly recognized. B cells undergo compartmentalized redistribution in blood and cerebrospinal fluid (CSF) during active MS, whereby memory B cells accumulate in the CSF. While B-cell trafficking across the blood-brain barrier has been intensely investigated, cellular diapedesis through the blood-CSF barrier (BCSFB) is incompletely understood. To investigate how B cells interact with the choroid plexus to transmigrate into the CSF we isolated circulating B cells from healthy donors (HC) and MS patients, utilized an inverted cell culture filter system of human choroid plexus papilloma (HIBCPP) cells to determine transmigration rates of B-cell subsets, immunofluorescence, and electron microscopy to analyze migration routes, and qRT-PCR to determine cytokines/chemokines mediating B-cell diapedesis. We also screened the transcriptome of intrathecal B cells from MS patients. We found, that spontaneous transmigration of HC- and MS-derived B cells was scant, yet increased significantly in response to B-cell specific chemokines CXCL-12/CXCL-13, was further boosted upon pre-activation and occurred via paracellular and transcellular pathways. Migrating cells exhibited upregulation of several genes involved in B-cell activation/migration and enhanced expression of chemokine receptors CXCR4/CXCR5, and were predominantly of isotype class switched memory phenotype. This antigen-experienced migratory subset displayed more pronounced chemotactic activities in MS than in HC and was retrieved in intrathecal B cells from patients with active MS. Trafficking of class-switched memory B cells was downscaled in a small cohort of natalizumab-exposed MS patients and the proportions of these phenotypes were reduced in peripheral blood yet were enriched intrathecally in patients who experienced recurrence of disease activity after withdrawal of natalizumab. Our findings highlight the relevance of the BCSFB as important gate for the entry of potentially harmful activated B cells into the CSF.
Copyright © 2021 Haas, Rudolph, Costa, Faller, Libicher, Würthwein, Jarius, Ishikawa, Stump-Guthier, Tenenbaum, Schwerk, Schroten and Wildemann.

Entities:  

Keywords:  B lymphocytes; blood-cerebrospinal fluid barrier; human; multiple sclerosis; transmigration

Mesh:

Year:  2021        PMID: 33574821      PMCID: PMC7870993          DOI: 10.3389/fimmu.2020.618544

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  44 in total

1.  Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin.

Authors:  Pia Kivisäkk; Don J Mahad; Melissa K Callahan; Corinna Trebst; Barbara Tucky; Tao Wei; Lijun Wu; Espen S Baekkevold; Hans Lassmann; Susan M Staugaitis; James J Campbell; Richard M Ransohoff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

Review 2.  Inflammatory cell migration into the central nervous system: a few new twists on an old tale.

Authors:  Shumei Man; Eroboghene E Ubogu; Richard M Ransohoff
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

3.  Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

Authors:  Amit Bar-Or; Lama Fawaz; Boli Fan; Peter J Darlington; Aja Rieger; Christine Ghorayeb; Peter A Calabresi; Emmanuelle Waubant; Stephen L Hauser; Jiameng Zhang; Craig H Smith
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

4.  Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

Authors:  Sabine Cepok; Berit Rosche; Verena Grummel; Friederike Vogel; Dun Zhou; Joachim Sayn; Norbert Sommer; Hans-Peter Hartung; Bernhard Hemmer
Journal:  Brain       Date:  2005-03-30       Impact factor: 13.501

Review 5.  Immunopathogenesis of multiple sclerosis.

Authors:  Manuel Comabella; Samia J Khoury
Journal:  Clin Immunol       Date:  2011-03-12       Impact factor: 3.969

6.  CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging.

Authors:  Kuti Baruch; Noga Ron-Harel; Hilah Gal; Aleksandra Deczkowska; Eric Shifrut; Wilfred Ndifon; Nataly Mirlas-Neisberg; Michal Cardon; Ilan Vaknin; Liora Cahalon; Tamara Berkutzki; Mark P Mattson; Fernando Gomez-Pinilla; Nir Friedman; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-18       Impact factor: 11.205

7.  T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients.

Authors:  Bettina Balint; Jürgen Haas; Alexander Schwarz; Sven Jarius; Alexandra Fürwentsches; Kathrin Engelhardt; Cornelia Bussmann; Friedrich Ebinger; Benedikt Fritzsching; Friedemann Paul; Ulrich Seidel; Stefan Vlaho; Peter Huppke; Jutta Gärtner; Brigitte Wildemann
Journal:  Neurology       Date:  2013-08-02       Impact factor: 9.910

Review 8.  B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation.

Authors:  Laure Michel; Hanane Touil; Natalia B Pikor; Jennifer L Gommerman; Alexandre Prat; Amit Bar-Or
Journal:  Front Immunol       Date:  2015-12-24       Impact factor: 7.561

9.  Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study.

Authors:  Lisa Lohmann; Claudia Janoschka; Andreas Schulte-Mecklenbeck; Svenja Klinsing; Lucienne Kirstein; Uta Hanning; Timo Wirth; Tilman Schneider-Hohendorf; Nicholas Schwab; Catharina C Gross; Maria Eveslage; Sven G Meuth; Heinz Wiendl; Luisa Klotz
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

10.  Culture models to study leukocyte trafficking across the choroid plexus.

Authors:  Tobias Tenenbaum; Ulrike Steinmann; Corinna Friedrich; Jürgen Berger; Christian Schwerk; Horst Schroten
Journal:  Fluids Barriers CNS       Date:  2013-01-10
View more
  5 in total

Review 1.  Breaching Brain Barriers: B Cell Migration in Multiple Sclerosis.

Authors:  Carla Rodriguez-Mogeda; Sabela Rodríguez-Lorenzo; Jiji Attia; Jack van Horssen; Maarten E Witte; Helga E de Vries
Journal:  Biomolecules       Date:  2022-06-07

Review 2.  What SARS-CoV-2 does to our brains.

Authors:  Tom Aschman; Ronja Mothes; Frank L Heppner; Helena Radbruch
Journal:  Immunity       Date:  2022-06-20       Impact factor: 43.474

Review 3.  B cells in central nervous system disease: diversity, locations and pathophysiology.

Authors:  Rajiv W Jain; V Wee Yong
Journal:  Nat Rev Immunol       Date:  2021-12-13       Impact factor: 108.555

Review 4.  The choroid plexus and its role in the pathogenesis of neurological infections.

Authors:  Derick Thompson; Catherine A Brissette; John A Watt
Journal:  Fluids Barriers CNS       Date:  2022-09-10

Review 5.  The CXCL13/CXCR5 Immune Axis in Health and Disease-Implications for Intrathecal B Cell Activities in Neuroinflammation.

Authors:  Christine Harrer; Ferdinand Otto; Richard Friedrich Radlberger; Tobias Moser; Georg Pilz; Peter Wipfler; Andrea Harrer
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.